MOREPENLAB financials

Chart ›
Latest results Q2 FY27 · Jul–Sep 2026
Revenue
₹747cr+81.4% on Q2 FY26
Net profit
₹88.9cr+117.5% on Q2 FY26
EBITDA margin
16.5%+9.0 pts on Q2 FY26
EPS
₹1.62+116.0% on Q2 FY26

Quarterly results

Every quarter ›
₹ croreQ2 FY27Q2 FY26Change
Revenue747412+81.4%
EBITDA12330.7+301.1%
EBITDA margin16.5%7.5%+9.0 pts
Profit before tax11745.7+155.0%
Net profit88.940.9+117.5%
EPS₹1.62₹0.75+116.0%

Over time

Q2 FY27 · Jul–Sep 2026latest
Revenue₹747 crNet profit₹88.9 crNet margin11.9%

Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.

Key numbersby financial year

₹ crore except per share
Tap a line for its trendCurrentlast 12M
171
0.8
2,286
276
12.1%
242
189
8.2%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

MOREPENLAB₹125.58

MOREPENLAB

₹ Crore
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
No consolidated annual data for MOREPENLAB yet.

Morepen Laboratories financials and key ratios

Prices at the 29 October 2026 close · figures from the company's filings with NSE

Morepen Laboratories (NSE: MOREPENLAB) had a market capitalisation of ₹6,537 crore at the 29 October 2026 close (₹119.31 a share), a PE ratio of 34.7 on the last four quarters' profit and a price-to-book ratio of 4.73. Its debt-to-equity ratio was 0.22 on 30 September 2026.

Share price used
₹119.31 · 29 October 2026 close
Latest balance sheet
30 September 2026

Morepen Laboratories at a glance · consolidated

Market cap
₹6,537 Crat ₹119.31 · 29 Oct close
PE ratio (last 4 quarters)
34.7
Price to book (PB)
4.73book value ₹25.21 a share
Debt to equity
0.22net debt ₹34 Cr
Dividend yield
0.17%₹0.20 a share in 12 months
Net worth
₹1,381 Cr+15.5% vs 30 Sep 202530 September 2026

Questions

What is the Morepen Laboratories PE ratio today?

Morepen Laboratories' PE ratio is 34.7 at the 29 October 2026 close (₹119.31 a share): a market capitalisation of ₹6,537 crore divided by consolidated net profit of ₹189 crore over the last four quarters (Q3 FY26 to Q2 FY27).

What is the Morepen Laboratories net worth?

Morepen Laboratories' net worth — shareholders' equity in its consolidated balance sheet — was ₹1,381 crore on 30 September 2026, up 15.5% from ₹1,196 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹6,537 crore at the 29 October 2026 close.

What is the Morepen Laboratories book value per share?

Morepen Laboratories' book value per share was ₹25.21 on 30 September 2026: shareholders' equity of ₹1,381 crore divided by the 54.79 crore shares in issue, up 15.5% from ₹21.83 a year earlier. The share price at the 29 October 2026 close was ₹119.31.

What is the Morepen Laboratories PB ratio (price to book value)?

Morepen Laboratories' price-to-book (PB) ratio is 4.73 at the 29 October 2026 close: a market capitalisation of ₹6,537 crore divided by shareholders' equity (book value) of ₹1,381 crore on 30 September 2026. That is a book value of ₹25.21 per share against a share price of ₹119.31.

What is the Morepen Laboratories dividend yield?

Morepen Laboratories' dividend yield is 0.17% at the 29 October 2026 close: dividends of ₹0.20 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹119.31. They were ₹0.20 on 18 September 2026.

What are the Morepen Laboratories latest quarterly results?

Morepen Laboratories' latest results are for Q2 FY27 (July–September 2026), filed on 27 October 2026: consolidated net profit ₹88.9 crore, up 117.5% from ₹40.9 crore in Q2 FY26; revenue from operations ₹747 crore, up 81.4% year on year.

What is the Morepen Laboratories market cap?

Morepen Laboratories' market capitalisation was ₹6,537 crore at the 29 October 2026 close: 54.79 crore shares at ₹119.31 each.

Is Morepen Laboratories debt free?

No. Morepen Laboratories had borrowings of ₹305 crore on 30 September 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.22. Its cash and current investments were ₹271 crore, so its net debt was ₹34 crore.

What is the Morepen Laboratories dividend in 2026 and its record date?

In 2026, Morepen Laboratories has declared one dividend: ₹0.20 with record date 19 September 2026 and ex-date 18 September 2026.

What is the Morepen Laboratories debt to equity ratio?

Morepen Laboratories' debt-to-equity ratio was 0.22 on 30 September 2026: borrowings of ₹305 crore against total equity of ₹1,382 crore. A year earlier, on 30 September 2025, it was 0.12.

When are the Morepen Laboratories next results?

Morepen Laboratories has reported Q2 FY27. Its next results, for Q3 FY27 (October–December 2026), are due by 14 February 2027 under SEBI's 45-day rule; the company notifies the board-meeting date at least two working days before.

Where do these Morepen Laboratories figures come from?

From Morepen Laboratories' own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 29 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.

Consolidated figures from the company's filings with NSE; prices are NSE closing prices.